NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

MEDP | NASDAQ

$595.41 $0.00 | 0.00%

Next Earnings: Sep 14, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
FWD PE *: 32.4x
Payout Ratio (TTM):
52-Week Range: $373.00 - $677.90

* Forward PE is based on street estimates.

7.6 Year MEDP Performance Metrics:

Total Return (with DRIP): 825% (34.00% CAGR)
Total Return (no DRIP): 825% (34.00% CAGR)
Share Price: 825% (34.00% CAGR)
Yield on Cost (with DRIP):
Total Invested: $10,000
Total Value (with DRIP): $92,455
Total Return $ (with DRIP): $82,455
MEDP Total Return
1Y 2Y 5Y 10Y All
MEDP Price Chart
1Y 2Y 5Y 10Y All
DRIPCalc.com
MEDP Price

Unlock All Reports & Research Dividend Stocks.

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)

MEDP Earnings, Revenue, Cash & Debt, Shares Outstanding:

MEDP - Revenue
MEDP Revenue CAGR:1Y: 17.24%2Y: 15.73%5Y: 20.51%10Y: 20.91%
MEDP - Earnings Per Share (EPS)
MEDP EPS CAGR:1Y: 37.10%2Y: 24.32%5Y: 32.01%10Y: 41.72%
MEDP - Net Income
🔒 Unlock
MEDP Net Income CAGR:1Y: 34.46%2Y: 17.20%5Y: 24.98%10Y: 37.67%
MEDP - EBITDA
🔒 Unlock
MEDP EBITDA CAGR:1Y: 1.73%2Y: 9.12%5Y: 22.93%10Y: 16.70%
MEDP - Free Cash Flow
🔒 Unlock
MEDP Free Cash Flow CAGR:1Y: -3.03%2Y: 15.50%5Y: 19.47%10Y: 39.29%
MEDP - Free Cash Flow / Share
🔒 Unlock
MEDP Free Cash Flow / Share CAGR:1Y: 1.02%2Y: 20.84%5Y: 25.27%10Y: 44.06%
MEDP - Operating Income
🔒 Unlock
MEDP Operating Income CAGR:1Y: 16.22%2Y: 18.17%5Y: 28.17%10Y: 26.39%
MEDP - Gross Profit
🔒 Unlock
MEDP Gross Profit CAGR:1Y: 12.01%2Y: 14.49%5Y: 21.99%10Y: 16.60%
MEDP - Shares Outstanding
🔒 Unlock
MEDP Shares Outstanding CAGR:1Y: -4.65%2Y: -5.32%5Y: -5.28%10Y: -3.16%
MEDP - Share Buybacks
🔒 Unlock
MEDP Share Buybacks CAGR:1Y: -45.51%2Y: 0.00%5Y: 39.46%10Y: 0.00%
MEDP - Stock-Based Comp
🔒 Unlock
MEDP Stock-Based Comp CAGR:1Y: -26.94%2Y: 10.08%5Y: 4.02%10Y: 2.90%
MEDP - Expenses
🔒 Unlock
MEDP Expenses CAGR:1Y: 291.15%2Y: 36.30%5Y: 31.82%10Y: 26.73%
MEDP - Revenue vs Net Income
🔒 Unlock
MEDP - EPS vs FCF / Share
🔒 Unlock
MEDP - EPS vs PE Ratio
🔒 Unlock
MEDP - FCF vs FCF / Share
🔒 Unlock
MEDP - FCF vs Stock Based Comp
🔒 Unlock
MEDP - Cash & Debt
🔒 Unlock
MEDP - Revenue by Segment
🔒 Unlock
MEDP Revenue CAGR:1Y: 17.24%2Y: 15.73%5Y: 20.51%10Y: 20.91%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

MEDP - REVENUE: Actual + Estimates
🔒 Unlock
MEDP Actual Revenue CAGR:1Y: 17.24%2Y: 15.73%5Y: 20.51%10Y: 20.91%
MEDP - EPS: Actual + Estimates
🔒 Unlock
MEDP Actual EPS CAGR:1Y: 37.10%2Y: 24.32%5Y: 32.01%10Y: 41.72%
MEDP - NET INCOME: Actual + Estimates
🔒 Unlock
MEDP Actual Net Income CAGR:1Y: 34.46%2Y: 17.20%5Y: 24.98%10Y: 37.67%
MEDP - EBITDA: Actual + Estimates
🔒 Unlock
MEDP Actual EBITDA CAGR:1Y: 1.73%2Y: 9.12%5Y: 22.93%10Y: 16.70%

Ratios, Profit Margins & Return on Capital:

MEDP - Net Profit Margin
🔒 Unlock
MEDP Net Profit Margin CAGR:1Y: 14.71%2Y: 1.28%5Y: 3.64%10Y: 13.87%
MEDP - Gross Profit Margin
🔒 Unlock
MEDP Gross Profit Margin CAGR:1Y: -4.46%2Y: -1.07%5Y: 1.23%10Y: -3.56%
MEDP - Price to Earnings
🔒 Unlock
MEDP - Price To Sales Ratio
🔒 Unlock
MEDP - Return on Capital Employed
🔒 Unlock
MEDP - Return on Invested Capital
🔒 Unlock

Compare stocks side-by-side
 

Projected Future Returns & Dividends for MEDP

Based on past 7.6-year performance, here are MEDP growth metrics:

Share price CAGR of +34%
Dividend CAGR of +0%

Using MEDP CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, is modelled to grow as follows:

MEDP (DRIP)MEDP - No DRIP
Current Price$595.41$595.41
Start Shares16.8016.80
Start Value$10,000$10,000
  
After 10 years:
Final Share Count16.8016.80
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$595.41$595.41
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - MEDP

NOTE: Above numbers are our estimate based on MEDP's Dividend and Price CAGR over past 7.6 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)

Company Info

Medpace Holdings, Inc. (MEDP) had its IPO on 2016-08-11, and is trader on NASDAQ stock exchange.

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

MEDP website: https://www.medpace.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)